Incannex Healthcare Ltd Stock Today
| IXHL Stock | USD 0.83 0.01 1.19% |
PerformanceVery Weak
| Odds Of DistressLow
|
Incannex Healthcare is selling for 0.83 as of the 22nd of March 2025. This is a 1.19% down since the beginning of the trading day. The stock's lowest day price was 0.81. Incannex Healthcare has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 2nd of March 2022 | Category Healthcare | Classification Health Care |
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. Incannex Healthcare Limited was incorporated in 2001 and is based in Melbourne, Australia. The company has 27.55 M outstanding shares of which 89.48 K shares are currently shorted by private and institutional investors with about 1.57 trading days to cover. More on Incannex Healthcare Ltd
Moving together with Incannex Stock
Moving against Incannex Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Incannex Stock Highlights
| CEO President | Joel Latham | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsIncannex Healthcare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Incannex Healthcare's financial leverage. It provides some insight into what part of Incannex Healthcare's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Incannex Healthcare Ltd (IXHL) is traded on NASDAQ Exchange in USA. It is located in 8 Century Circuit, Sydney, NSW, Australia, 2153 and employs 9 people. Incannex Healthcare is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.22 M. Incannex Healthcare conducts business under Biotechnology sector and is part of Health Care industry. The entity has 27.55 M outstanding shares of which 89.48 K shares are currently shorted by private and institutional investors with about 1.57 trading days to cover.
Incannex Healthcare Ltd currently holds about 37.5 M in cash with (15.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68.
Check Incannex Healthcare Probability Of Bankruptcy
Ownership AllocationIncannex Healthcare Ltd has a total of 27.55 Million outstanding shares. Incannex Healthcare secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Incannex Ownership Details
Incannex Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Qube Research & Technologies | 2024-09-30 | 0.0 | |
| Tidal Investments Llc. | 2024-12-31 | 0.0 | |
| Jpmorgan Chase & Co | 2024-12-31 | 0.0 | |
| Virtu Financial Llc | 2024-12-31 | 0.0 | |
| Bank Of America Corp | 2024-09-30 | 0.0 | |
| Hrt Financial Llc | 2024-12-31 | 0.0 | |
| Advisorshares Investments, Llc | 2024-12-31 | 165.5 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 56.4 K | |
| Jane Street Group Llc | 2024-12-31 | 47.3 K | |
| Bridgeway Capital Management, Llc | 2024-12-31 | 25 K | |
| Barclays Plc | 2024-12-31 | 22.5 K |
Incannex Healthcare Historical Income Statement
Incannex Stock Against Markets
Incannex Healthcare Corporate Management
| Mark Bleackley | Head Officer | Profile | |
| BSc EMBA | Chief IncannexTM | Profile | |
| Rosemarie Walsh | VP Board | Profile | |
| Lekhram MSc | Chief Officer | Profile | |
| Madhukar Bhalla | CFO Sec | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.42) | Revenue Per Share | Quarterly Revenue Growth 0.296 | Return On Assets | Return On Equity |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.